Program
Preliminary program subject to change.
Topics:
1. Deep Brain Stimulation (DBS)
2. Electroconvulsive Therapy (ECT)
3. Epidural Cortical Stimulation and Microstimulation
4. Transcranial Ultrasound Stimulation (tUS) / Low Intensity Focused Ultrasound (LIFU)
5. Pulsed Ultrasound (pUS)
6. High Intensity Focused Ultrasound (HIFU)
7. Transcranial Magnetic Stimulation (TMS)
8. Transcranial Alternating Current Stimulation (tACS)
9. Transcranial Direct Current Stimulation (tDCS)
10. Transcranial Random Noise Stimulation (tRNS)
11. Vagus Nerve Stimulation (VNS) and Cranial Nerve Stimulation
12. Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS)
13. Transcranial photobiomodulation (tPBM) and Light Based Neuromodulation
14. Temporal Interference Stimulation
15. Neuroprostheses / Functional Electrical Stimulation
16. Focal Pharmacology
17. Brain-computer Interfaces and bidirectional BC
18. Other Techniques
Experimental Models (Optional)
19. Modeling and computational methods
20. Cellular / in vitro Mechanisms of Stimulation
21. Preclinical models
22. Electroencephalography (EEG) / Magnetoencephalography (MEG)
23. Electromyography (EMG)
24. Functional Brain Imaging
25. Structural Brain Imaging
26. Hardware / Power / Electrode Design
27. Neuronavigation
Purpose / Application (Optional)
28. Focal Pharmacology
29. Responsive (Closed-Loop) Stimulation
30. Brain-computer Interfaces and bidirectional BC
31. Neuroprostheses
32. Neurorehabilitation
33. Neuropharmacology
34. Neurophysiology
35. Neuroplasticity
36. Neuropsychology
Industry Sponsored Workshops
Registration for these industry sponsor workshops will open shortly. Sunday, 21 February 2027, 10:00 - 17:00 Soritex Medical
Advanced Neuromodulation and Neuromonitoring Training Workshop with Updates on the Latest Technologies The workshop will focus on fundamentals and advanced applications of non-invasive neuromodulation and neuromonitoring technologies, with in-depth product demonstrations and hands-on training.
Topics include:
Conventional and High Definition transcranial Electrical Stimulation (tES/HD-tES)
Remote Supervised tDCS/tES and HD-tES
Our first hybrid HD-tES and EEG solution (MXN-GO EEG)
Temporal Interference (TI) / Interferential Stimulation (IFS)
Repetitive transcranial Magnetic Stimulation (rTMS) with Soterix Medical SPRY TMS and Neuronavigation
Transcranial-focused Ultrasound Stimulation (tFUS)
Galvanic Vestibular Stimulation (GVS), transcutaneous Auricular Vagus Nerve
Stimulation (taVNS), and closed-loop transcranial Electrical Stimulation (tES) and monitoring
New and upcoming technologies
Sunday, 21 February 2027 MagVenture Theme: Next wave of convulsive therapy using MagVenture MST Technology
Part 1: 10:00 - 13:00 Education in MST — the next wave of convulsive therapy using Non-invasive Electromagnetic Ultra Rapid Onset Neuromodulation Therapy Part 2: 14:00 - 17:00 MST early pioneer training and technology certification with full demo + hands-on with the equipment
Monday, 22 February 2027, 7:30 - 8:30 MagVenture Next-gen TMS technology — personalization, accelerated, precision-enabled TMS
Tuesday, 23 February 2027, 7:30 - 8:30 MagVenture Future of convulsive therapy — MST (MagVenture NEURON™ Therapy)
Tuesday, 23 February 2027, 7:30 - 8:30 Livanova Implementing VNS Therapy for Difficult to Treat Depression in Clinical Practice - Practical Experience and Best Practice
This clinical workshop explores the practical implementation of implantable Vagus Nerve Stimulation (VNS) Therapy for patients with difficult‑to‑treat depression. Drawing on expert consensus statements and real‑world clinical experience and the latest data from the RECOVER randomised control trial, the session will address patient selection, treatment pathways and long‑term management. Best‑practice recommendations will be discussed, alongside case examples illustrating common challenges and solutions, to support clinicians in safely and effectively integrating VNS Therapy into routine clinical practice.
REGISTRATION LINK COMING SOON
Wednesday, 24 February 2027, 7:30 - 8:30 STORZ MEDICAL Transcranial Pulse Stimulation (TPS) for Non-Invasive Brain Stimulation: Latest Advances and Future Directions
Transcranial Pulse Stimulation (TPS) is an innovative treatment for patients with Alzheimer’s dementia, utilizing low-energy acoustic pulse waves to target affected brain regions.
The NEUROLITH device, CE-approved since 2018, is designed for TPS treatment and delivers energy non-invasively, reaching depths of up to 8 centimetres. A standard TPS treatment protocol involves six sessions within two weeks, with each session lasting approximately 30 minutes. Follow-up sessions are tailored individually, typically scheduled 4 to 8 weeks after the initial treatment series. The TPS application is visually monitored, enabling real-time tracking of targeted brain areas, ensuring accuracy and safety.